glp-1 gastrointestinal obstruction legal team in louisiana gastric intestinal GLP-1 for Crohn's Disease: Current Evidence and Treatment Options Ozempic Lawsuit Update May 2026
Description
Fort Smith, AR
Recent developments underscore the relevance of GLP-1R agonists in addressing the complex interplay of cardiovascular-kidney-metabolic (CKM) syndrome, microvascular dysfunction, and metabolic-associated steatohepatitis (MASH)
A University of Miami study found GLP1 therapy significantly improved freedom from atrial fibrillation after ablation in obese patients.
Health Canada says unauthorized versions of glucagon-like peptide-1 (GLP-1) receptor agonist drugs, are appearing for sale both online and in stores across Canada
This is all well and good for people with obesity (PwO) who also have diabetes, but what if Mr T had obesity without diabetes
Repatha (evolocumab) is a PCSK9 inhibitor that cuts LDL by ~60% when statins aren't enough
